In contrast, small-molecule targeted therapies, especially those targeting EGFR, showed higher specificity and sensitivity in EGFR-mutated lung cancer cell lines cultured in the 3D system, suggesting altered receptor expression and signaling compared to 2D models. The gene discussed is EGFR; the disease is lung carcinoma.